APA
TARS icon

American Portfolios Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

American Portfolios Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$668 Hold
39
– – ﹤0.01% 3343
2022
Q2 		$569 Hold
39
– – ﹤0.01% 3374
2022
Q1 		$656 Hold
39
– – ﹤0.01% 3430
2021
Q4 		$878 Hold
39
– – ﹤0.01% 3342
2021
Q3 		$840 Buy
+39
New +$965 ﹤0.01% 3331

Other funds holding TARS

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Portfolios Advisors's TARS Position: Q3 2022 in Review

American Portfolios Advisors held its Tarsus Pharmaceuticals (TARS) position steady in Q3 2022 at 39 shares worth $668. The position accounts for ﹤0.01% of the portfolio, ranked #3343.

American Portfolios Advisors first reported a position in TARS in Q3 2021 and has held it in 5 quarters since. The position peaked at $878 in Q4 2021. 75 funds tracked by Wall St. Rank hold TARS as of Q3 2022.

  • American Portfolios Advisors held 39 shares of Tarsus Pharmaceuticals worth $668 as of Q3 2022.
  • American Portfolios Advisors left its Tarsus Pharmaceuticals share count unchanged in Q3 2022.
  • Tarsus Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3343 holding.
  • American Portfolios Advisors first reported a position in Tarsus Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
  • American Portfolios Advisors's Tarsus Pharmaceuticals position peaked at $878 in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.